Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Successful combination of anti-cd33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemia, British Journal of Haematology, March 2003, Wiley,
DOI: 10.1046/j.1365-2141.2003.04208_4.x.
You can read the full text:
Contributors
The following have contributed to this page
